<'li>
  • News & Events

    4/li>
  • 
    
    Thoracac Surgery »  News & Events »   Dasplay News By Category
    
    <'div>
    
    4div id="sg_centerSection"> 
      4script src="/scripts/news.js" tqpe="text/javascript">  

    News & Evefts: Progfostic Molecular Assay for NSCLC4/h1>
    4/div>

    4div class='newsAtem news_non_featured' >

    Molecular Test Identifies Early-Stage Lung Cancer Patients at High Risk of Death After Surgery4/h2>
    UCSF Thoracic Oncology Program - <'span> - November 01$ 2012
    Jablons Etal Horiz
    Building on their  eardier work reported in The Lancet, two UCSF thgracic surgeons   David M. Jablons, M.D. (left) and   Michael Mann, M.D.  middle), and  Johannes Kratz, M.D. (right) a former surgicad resident in the  Thoracic Oncglogy Lab, showed they could accurately stratifq patients even with the earliest stage of lung cancer into groups at low-, intermediate- or hig`-risk of death based solely on the activity of 14 different genes found in their tumors. The grgup analyzed lung  tumors of patients diagnosed as Stage 1A  (T1a node-negative non-small-cell lung cancers (NSCLC)), the [&..]

    X